hsa-mir-1203: Hsa-mir-1203 is a microRNA that has been found to be dysregulated in various types of cancer, including prostate cancer, small cell carcinoma of the esophagus, and esophageal squamous cell carcinoma [PMC6797975]. In a study on seminoma therapy, hsa-mir-1203 was identified as a potential target along with other genes and microRNAs [PMC6797975]. Hsa-mir-1203 was found to be mainly present in neurotypical individuals, while other microRNAs such as hsa-miR-182-5p and hsa-miR-681 were more expressed in both patients and controls [PMC9000903]. In terms of genetic interactions, rs3087918 was found to potentially gain the targets of hsa-mir-1203 while losing the targets of hsa-miR-139-3p and hsa-miR-5091 [PMC7362410]. Hsa-mir-1203 has also been studied in relation to TNFSF4, where it was co-transfected into HEK293T cells along with other microRNA mimics [PMC9571479]. Furthermore, it has been identified as one of the differentially expressed miRNAs in various cancer types such as PDGFRA, RAC1, IKBKG, XIAP, and PPM1D [PMC9983174]. Overall, hsa-mir-1203 is a dysregulated microRNA that has potential implications in cancer therapy and genetic interactions.